TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,334 | -3.9% | 12,562 | -2.4% | 0.02% | 0.0% |
| Q2 2023 | $202,203 | -4.7% | 12,871 | 0.0% | 0.02% | -10.7% |
| Q1 2023 | $212,114 | +5.6% | 12,871 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $200,788 | +20.2% | 12,871 | 0.0% | 0.03% | +3.7% |
| Q3 2022 | $167,000 | -8.2% | 12,871 | +26.7% | 0.03% | -27.0% |
| Q2 2020 | $182,000 | – | 10,156 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |